- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Synthesis of pan-JAK Inhibitor PF-06263276 ; volume:15 ; number:12 ; year:2019 ; pages:1343
Synfacts ; 15, Heft 12 (2019), 1343
- DOI
-
10.1055/s-0039-1691094
- URN
-
urn:nbn:de:101:1-2020012008184266903362
- Rights
-
Open Access unbekannt; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
01.08.2025, 8:58 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Other Objects (12)
Synthesis of SMO Inhibitor PF-04449913
Hemmung des JAK/STAT3-Pathways mit JAK-Inhibitoren in Mammakarzinomen
Hammer Jak.Edmund Ob.Insp. Landau/Pf.
JAK Inhibitors for Myelofibrosis: Strengths and Limitations
JAK-Inhibitoren für die Behandlung hämatoonkologischer Erkrankungen
Stellenwert der JAK-Inhibitoren („small is beautiful“)
JAK Inhibitors in Rheumatology: Implications for Paediatric Syndromes?
Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application
Systemic Treatment of Psoriasis with JAK Inhibitors: A Review
Managing Cardiovascular and Cancer Risk Associated with JAK Inhibitors
Macrophage re-programming by JAK inhibitors relies on MAFB
Small Molecule Inhibitors of Interferon‐Induced JAK‐STAT Signalling
Synthesis of SMO Inhibitor PF-04449913
Hemmung des JAK/STAT3-Pathways mit JAK-Inhibitoren in Mammakarzinomen
Hammer Jak.Edmund Ob.Insp. Landau/Pf.
JAK Inhibitors for Myelofibrosis: Strengths and Limitations
JAK-Inhibitoren für die Behandlung hämatoonkologischer Erkrankungen
Stellenwert der JAK-Inhibitoren („small is beautiful“)
JAK Inhibitors in Rheumatology: Implications for Paediatric Syndromes?
Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application
Systemic Treatment of Psoriasis with JAK Inhibitors: A Review
Managing Cardiovascular and Cancer Risk Associated with JAK Inhibitors
Macrophage re-programming by JAK inhibitors relies on MAFB
Small Molecule Inhibitors of Interferon‐Induced JAK‐STAT Signalling
Synthesis of SMO Inhibitor PF-04449913
Hemmung des JAK/STAT3-Pathways mit JAK-Inhibitoren in Mammakarzinomen
Hammer Jak.Edmund Ob.Insp. Landau/Pf.
JAK Inhibitors for Myelofibrosis: Strengths and Limitations
JAK-Inhibitoren für die Behandlung hämatoonkologischer Erkrankungen
Stellenwert der JAK-Inhibitoren („small is beautiful“)
JAK Inhibitors in Rheumatology: Implications for Paediatric Syndromes?
Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application
Systemic Treatment of Psoriasis with JAK Inhibitors: A Review
Managing Cardiovascular and Cancer Risk Associated with JAK Inhibitors
Macrophage re-programming by JAK inhibitors relies on MAFB